HomeCompareBRP vs GBDC

BRP vs GBDC: Dividend Comparison 2026

BRP yields 6.12% · GBDC yields 11.86%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GBDC wins by $20.82M in total portfolio value
10 years
BRP
BRP
● Live price
6.12%
Share price
$32.66
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.0K
Annual income
$904.58
Full BRP calculator →
GBDC
GBDC
● Live price
11.86%
Share price
$12.65
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.85M
Annual income
$16,450,733.83
Full GBDC calculator →

Portfolio growth — BRP vs GBDC

📍 GBDC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBRPGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BRP + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BRP pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BRP
Annual income on $10K today (after 15% tax)
$520.51/yr
After 10yr DRIP, annual income (after tax)
$768.89/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.91/yr
After 10yr DRIP, annual income (after tax)
$13,983,123.76/yr
At 15% tax rate, GBDC beats the other by $13,982,354.86/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BRP + GBDC for your $10,000?

BRP: 50%GBDC: 50%
100% GBDC50/50100% BRP
Portfolio after 10yr
$10.44M
Annual income
$8,225,819.21/yr
Blended yield
78.79%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BRP right now

BRP
Analyst Ratings
1
Strong
8
Buy
4
Hold
Consensus: Buy
Price Target
$31.00
-5.1% upside vs current
Range: $26.00 — $34.00
Altman Z
0.8
Piotroski
3/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.7% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BRP buys
0
GBDC buys
0
No recent congressional trades found for BRP or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBRPGBDC
Forward yield6.12%11.86%
Annual dividend / share$2.00$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.1%
Portfolio after 10y$30.0K$20.85M
Annual income after 10y$904.58$16,450,733.83
Total dividends collected$7.6K$20.43M
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusBuyBuy
Analyst price target$31.00$14.00

Year-by-year: BRP vs GBDC ($10,000, DRIP)

YearBRP PortfolioBRP Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$11,312$612.37$12,492$1,791.70$1.2KGBDC
2$12,752$647.42$16,527$3,160.58$3.8KGBDC
3$14,326$682.04$23,588$5,904.90$9.3KGBDC
4$16,045$716.14$37,141$11,901.65$21.1KGBDC
5$17,918$749.59$66,205$26,463.38$48.3KGBDC
6$19,955$782.32$137,452$66,612.65$117.5KGBDC
7$22,166$814.25$342,372$195,298.53$320.2KGBDC
8$24,563$845.30$1,053,292$686,954.33$1.03MGBDC
9$27,157$875.42$4,111,439$2,984,416.95$4.08MGBDC
10$29,963$904.58$20,849,974$16,450,733.83$20.82MGBDC

BRP vs GBDC: Complete Analysis 2026

BRPStock

BRP Group, Inc. markets and sells insurance products and services in the United States. The company operates through four segments: Middle Market, Specialty, MainStreet, and Medicare. The Middle Market segment provides commercial risk management, employee benefits solutions, and private risk management for mid-to-large size businesses and high net worth individuals, as well as its families. The Specialty segment delivers specialty insurers, professionals, individuals, and industry businesses the access to specialty markets, as well as capabilities and programs requiring underwriting and placement. This segment also operates as a managing general agent of the Future platform, which delivers proprietary, technology-enabled insurance solutions. The MainStreet segment offers personal insurance, commercial insurance, and life and health solutions to individuals and businesses in its communities. The Medicare segment provides consultation for government assistance programs and solutions, including Medicare and Medicare Advantage to seniors and Medicare-eligible individuals through a network of primarily independent contractor agents. The company was founded in 2011 and is headquartered in Tampa, Florida.

Full BRP Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this BRP vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BRP vs SCHDBRP vs JEPIBRP vs OBRP vs KOBRP vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.